Carl Erik Mogensen

Carl Erik Mogensen's AcademicInfluence.com Rankings

Carl Erik Mogensen

Philosophy

#2825

World Rank

#4707

Historical Rank

Logic

#803

World Rank

#1343

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Carl Erik Mogensen's Degrees

Doctorate Medicine University of Copenhagen

Why Is Carl Erik Mogensen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Carl Erik Mogensen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (2008) (5018)
The glomerular permeability determined by dextran clearance using Sephadex gel filtration. (1968) (2346)
Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. (1984) (2028)
Predicting diabetic nephropathy in insulin-dependent patients. (1984) (1637)
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study (2000) (1069)
The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy (1983) (896)
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy (1982) (785)
Nephropathy in diabetes. (2004) (698)
Microalbuminuria as predictor of increased mortality in elderly people. (1990) (642)
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study (2005) (603)
Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study (2003) (598)
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria (1994) (576)
Prevention of diabetic renal disease with special reference to microalbuminuria (1995) (567)
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
Microalbuminuria: an early marker of renal involvement in diabetes. (1985) (470)
Increased urinary albumin-excretion rate in benign essential hypertension. (1974) (436)
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. (1994) (435)
Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. (1976) (382)
Free insulin-like growth factors in human obesity. (1995) (361)
Increased Kidney Size and Glomerular Filtration Rate in Early Juvenile Diabetes (1973) (340)
Muscle strength in type 2 diabetes. (2004) (331)
Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. (1995) (330)
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. (2014) (315)
Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas (1999) (297)
Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. (1986) (269)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
Radioimmunoassay for urinary albumin using a single antibody. (1970) (262)
Lowering blood pressure reduces renal events in type 2 diabetes. (2009) (251)
Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. (1977) (249)
Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes * (2003) (244)
Microalbuminuria and Potential Confounders: A review and some observations on variability of urinary albumin excretion (1995) (243)
Maximum tubular reabsorption capacity for glucose and renal hemodynamcis during rapid hypertonic glucose infusion in normal and diabetic subjects. (1971) (220)
Prediction of Clinical Diabetic Nephropathy in IDDM Patients: Alternatives to Microalbuminuria? (1990) (208)
Ambulatory Blood Pressure in the Transition from Normo- to Microalbuminuria: A Longitudinal Study in IDDM Patients (1994) (196)
Isokinetic Muscle Strength in Long-Term IDDM Patients in Relation to Diabetic Complications (1996) (189)
Urinary albumin excretion in early and long-term juvenile diabetes. (1971) (179)
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study (2002) (177)
Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. (2003) (176)
How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature (1996) (175)
Kidney function and glomerular permeability to macromolecules in early juvenile diabetes. (1971) (157)
Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER (2003) (155)
Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. (1971) (154)
Diabetic Kidney Disease– A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) (2014) (154)
The Course of Incipient Diabetic Nephropathy: Studies of albumin excretion and blood pressure (1985) (152)
Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria (1996) (151)
Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes. (2015) (150)
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. (2002) (147)
Eight to nine year mortality in known non-insulin dependent diabetics and controls. (1992) (145)
Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? (1993) (141)
Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy (2004) (139)
Urinary albumin excretion during exercise in juvenile diabetes. A provocation test for early abnormalities. (1975) (136)
Microalbuminuria in Elderly Hyperglycaemic Patients and Controls (1986) (135)
Effect of Antihypertensive Treatment on Progression of Incipient Diabetic Nephropathy (1985) (126)
Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment (1975) (123)
The kidney and hypertension in diabetes mellitus (1989) (123)
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. (2013) (122)
Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study. (2003) (121)
Renal function changes in diabetes. (1976) (120)
Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension. (1976) (120)
Pronounced increase in serum creatinine concentration after eating cooked meat. (1979) (114)
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. (2006) (113)
Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent "isolated" diastolic dysfunction. (2003) (111)
Elevated levels of mannan-binding lectin in patients with type 1 diabetes. (2003) (110)
Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study. (2005) (110)
Abnormal albumin excretion after two provocative renal tests in diabetes: physical exercise and lysine injection. (1979) (108)
Prediction of kidney-related outcomes in patients with type 2 diabetes. (2012) (106)
Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. (2002) (102)
Blood Pressure Changes and Renal Function in Incipient and Overt Diabetic Nephropathy (1985) (102)
Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. (2002) (101)
Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. (1992) (96)
Blood Pressure Elevation Versus Abnormal Albuminuria in the Genesis and Prediction of Renal Disease in Diabetes (1992) (91)
Combined high blood pressure and glucose in type 2 diabetes: double jeopardy (1998) (91)
Effect of Insulin Pump Treatment for One Year on Renal Function and Retinal Morphology in Patients with IDDM (1985) (88)
The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics (1976) (88)
Urinary excretion of albumin in normal man: the effect of water loading. (1982) (85)
Reduction of Glomerular Hyperfiltration in Normoalbuminuric IDDM Patients by 6 mo of Aldose Reductase Inhibition (1991) (84)
Graded exercise and protein excretion in diabetic man and the effect of insulin treatment. (1982) (79)
[Predicting diabetic nephropathy]. (1984) (79)
Glomerular filtration rate and renal plasma flow in normal and diabetic man during elevation of blood sugar levels. (1971) (78)
Consensus Development Conference on the Diagnosis and Management of Nephropathy in Patients with Diabetes Mellitus (1994) (78)
Comparative renal pathophysiology relevant to IDDM and NIDDM patients. (1988) (78)
Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study “Diabetes Care in General Practice”, Denmark (1993) (72)
Autonomic and Somatosensory Nerve Function After 2 Years of Continuous Subcutaneous Insulin Infusion in Type I Diabetes (1988) (70)
Microalbuminuria in non-insulin-dependent diabetes. (1992) (69)
MANAGEMENT OF DIABETIC RENAL INVOLVEMENT AND DISEASE (1988) (68)
Introduction: Diabetes mellitus and the kidney (1982) (68)
Renal Factors Influencing Blood Pressure Threshold and Choice of Treatment for Hypertension in IDDM (1991) (66)
Acute effects of insulin on plasma noradrenaline and the cardiovascular system. (1980) (66)
Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function. (1987) (65)
The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy (2006) (64)
Glomerular Filtration Rate and Renal Plasma Flow in Long-term Juvenile Diabetics without Proteinuria (1972) (63)
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients (2009) (60)
Kidney function in normal man during short-term growth hormone infusion. (1978) (60)
Systolic Blood Pressure Relates to the Rate of Decline of Glomerular Filtration Rate in Type II Diabetes (1993) (59)
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. (2004) (58)
Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention. (1993) (56)
Birth weight and cardiovascular risk factors in an epidemiological study (1996) (55)
Impact of essential hypertension and diabetes mellitus on left ventricular systolic and diastolic performance. (2003) (54)
Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension (2005) (53)
EVALUATION OF KIDNEY FUNCTION AFTER MEALS (1980) (53)
Similar Insulin Sensitivity in NIDDM Patients With Normo- and Microalbuminuria (1995) (51)
Cardiac Hyperfunction in Insulin-Dependent Diabetic Patients Developing Microvascular Complications (1988) (51)
Night blood pressure and cigarette smoking: disparate association in healthy subjects and diabetic patients. (1994) (51)
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes. (2008) (50)
Diabetic renal disease: from recent studies to improved clinical practice (2004) (50)
Angiotensin converting enzyme inhibitors and diabetic nephropathy. (1992) (49)
Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study. (1997) (49)
New treatment guidelines for a patient with diabetes and hypertension. (2003) (47)
Normoalbuminuria ensures no reduction of renal function in type 1 (insulin‐dependent) diabetic patients (1992) (46)
Does microalbuminuria predict diabetic nephropathy? (2002) (46)
Acute Effects of a Somatostatin Analogue on Kidney Function in Type 1 Diabetic Patients (1990) (45)
Circadian variation of blood pressure in patients with diabetic nephropathy (1992) (44)
The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system (2014) (44)
Renoprotective role of ACE inhibitors in diabetic nephropathy. (1994) (43)
Glomerular Hyperfiltration in Human Diabetes (1994) (42)
The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics (1980) (42)
St Vincent Declaration, 1994: Guidelines for the Prevention of Diabetic Renal Failure (1994) (42)
Albuminuria and 24-h Ambulatory Blood Pressure in Normoalbuminuric and Microalbuminuric NIDDM Patients. A longitudinal study (1995) (41)
Definition of Diabetic Renal Disease in Insulin-Dependent Diabetes Mellitus Based on Renal Function Tests (2000) (40)
The acute effect of insulin on heart rate, blood pressure, plasma noradrenaline and urinary albumin excretion (1980) (39)
Increased blood pressure in diabetes: essential hypertension or diabetic nephropathy? (1987) (39)
Autonomic neuropathy in nondiabetic offspring of type 2 diabetic subjects is associated with urinary albumin excretion rate and 24-h ambulatory blood pressure: the Fredericia Study. (2001) (39)
Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: a 2 year controlled study. (1987) (39)
Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. (2005) (39)
Effect on renal haemodynamics, glomerular filtration rate and albumin excretion of high oral protein load. (1986) (39)
Preventing end‐stage renal disease (1998) (37)
Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy. (1992) (37)
Determinants of 24-H Blood Pressure in IDDM Patients (1995) (37)
INCREASED URINARY EXCRETION OF ALBUMIN, LIGHT CHAINS, AND β2-MUCROGLOBULIN AFTER INTRAVENOUS ARGININE ADMINISTRATION IN NORMAL MAN (1975) (35)
MICROALBUMINURIA PREDICTS PROLIFERATIVE DIABETIC RETINOPATHY (1985) (34)
Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: insights from the RENAAL study. (2005) (34)
Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition. (1992) (32)
Simvastatin Reduces Plasma Osteoprotegerin in Type 2 Diabetic Patients With Microalbuminuria (2007) (32)
Latin American consensus on diabetes mellitus and hypertension. (2004) (31)
Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment (1993) (31)
Effects of exercise on urinary excretion of albumin and beta 2-microglobulin in young patients with mild essential hypertension without treatment and during long-term propranolol treatment. (1981) (31)
Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study. (2008) (31)
Albumin excretion and renal haemodynamic response to physical exercise in normal and diabetic man. (1981) (30)
Diabetic nephropathy. (2003) (30)
Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients. (1995) (30)
Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabetics. (1990) (29)
Management of early nephropathy in diabetic patients. (1995) (29)
The renal handling of amylase in normal man. (1979) (29)
Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function. (1999) (29)
Prevention and treatment of renal disease in insulin-dependent diabetes mellitus. (1990) (29)
Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycaemic control. (1992) (29)
Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy. (1986) (29)
Myocardial injury with biomarker elevation in diabetic ketoacidosis. (2005) (29)
Microalbuminuria, glycemic control, and blood pressure predicting outcome in diabetes type 1 and type 2. (2004) (28)
Renal effects from limitation of high dietary protein in normoalbuminuric diabetic patients. (1989) (27)
The kidney in diabetes: how to control renal and related cardiovascular complications. (2001) (27)
Microalbuminuria: studies in diabetes, essential hypertension, and renal diseases as compared with the background population. (1991) (27)
Functional and morphological renal manifestations in diabetes mellitus (1981) (27)
Clinical Evaluation of a Test for Immediate and Quantitative Determination of Urinary Albumin-to-Creatinine Ratio: A brief report (1998) (27)
Drug treatment for hypertensive patients in special situations: diabetes and hypertension. (1999) (26)
Renal protein handling in normal, hypertensive and diabetic man. (1981) (26)
High blood pressure as a factor in the progression of diabetic nephropathy. (2009) (26)
Relationship between Renal Size and Function in Normal Subjects (1973) (26)
Prevention and Treatment of Diabetic Late Complications (1989) (26)
The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products. (2009) (26)
Diabetic Renal Disease: The Quest for Normotension—and Beyond (1995) (26)
Elevated glomerular filtration rate in insulin-treated short-term diabetes. Non-dependence on blood sugar value. (2009) (25)
Twelve shifting paradigms in diabetic renal disease and hypertension. (2008) (25)
Early functional and morphologic vascular renal consequences of the diabetic state (2004) (25)
The acute effect of insulin on renal haemodynamics and protein excretion in diabetics (1978) (23)
Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study. (1987) (23)
Predictors of mortality of patients newly diagnosed with clinical type 2 diabetes: a 5-year follow up study (2010) (23)
Microvascular permeability to albumin and glomerular filtration rate in diabetic and normal children. (1979) (23)
The effect of short-term glucagon infusion on kidney function in normal man (1977) (23)
Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement. (1990) (23)
Low birth weight – is it associated with few and small glomeruli in normal subjects and NIDDM patients? (1996) (23)
Quantitative studies of glomerular ultrastructure in human and experimental diabetes. (1984) (23)
Natural history of cardiovascular and renal disease in patients with type 2 diabetes: effect of therapeutic interventions and risk modification. (1998) (22)
Evaluation of a dipstick test for microalbuminuria in three different clinical settings, including the correlation with urinary albumin excretion rate. (1992) (22)
Studies on mechanisms of proteinuria using amino-acid-induced inhibition of tubular reabsorption in normal and diabetic man. (1981) (22)
The reno-protective role of AT1-receptor blockers (2002) (21)
Echocardiographic-determined left ventricular wall characteristics in insulin-dependent diabetic patients. (2009) (21)
Plasma concentrations of osteoprotegerin during normo‐ and hyperglycaemic clamping (2007) (21)
New concepts in diabetes and its treatment (2000) (20)
Early functional and morphologic vascular renal consequences of the diabetic state (1979) (20)
Antihypertensive treatment inhibiting the progression of diabetic nephropathy. (1980) (20)
ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment. (1991) (20)
Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin (Short Communication) (1999) (19)
Pharmacotherapy of Diabetes: New Developments (2007) (19)
Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis. (2008) (18)
Urinary excretion of albumin, beta-2-microglobulin and light chains in pre-eclampsia, essential hypertension in pregnancy and normotensive pregnant and non-pregnant control subjects (1981) (18)
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: Evidence for and against the combination in the treatment of hypertension and proteinuria (2002) (18)
Increased left ventricular systolic function in insulin dependent diabetic patients with normal albumin excretion. (1998) (18)
Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus? (1994) (17)
The effect of blood pressure intervention on renal function in insulin-dependent diabetes. (1989) (17)
Oral glucose increases urinary albumin excretion in normal subjects but not in insulin-dependent diabetics. (1980) (17)
Effect of pump versus pen treatment on glycaemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM). (1989) (17)
[Dual blockade of the renin-angiotensin system]. (2004) (17)
Effects of felodipine on urinary albumin excretion and metabolic control in hypertensive non-insulin-dependent diabetics. (1990) (17)
Over-mortality as related to age and gender in patients with established non-insulin-dependent diabetes mellitus. (1997) (16)
Postprandial serum creatinine increase in normal subjects after eating cooked meat. (1979) (16)
Urinary excretion of albumin beta2-microglobulin and free light chains during lithium treatment. (1978) (15)
Normal blood pressure and preserved diurnal variation in offspring of type 2 diabetic patients characterized by features of the metabolic syndrome: the Fredericia Study. (2000) (15)
Evaluation of a New Semiquantitative Stix for Microalbuminuria (1995) (15)
Genetics and diabetic renal disease: still a big black hole. (2003) (15)
Effects of blood pressure lowering and metabolic control on systolic left ventricular function in Type II diabetes mellitus. (2006) (15)
Urinary albumin excretion in diabetes. (1971) (15)
Kidney function in acromegaly. (2009) (15)
Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease (2004) (14)
Elevated Ambulatory Blood Pressure in Microalbuminuric IDDM Patients Is Inversely Associated With Renal Plasma Flow: A compensatory mechanism? (1997) (14)
Enhancement of glomerular filtration rate and renal plasma flow by oral glucose load in well controlled insulin-dependent diabetics. (1986) (13)
Microalbuminuria, early blood pressure elevation, and diabetic renal disease (1994) (13)
Albumin and beta 2-microglobulin excretion in patients on long-term lithium treatment. (1981) (13)
Enhanced urinary excretion of albumin and beta 2 microglobulin in essential hypertension induced by atrial natriuretic peptide. (1991) (13)
Studies on the mechanism of renal tubular protein reabsorption. (1977) (13)
Urinary albumin excretion rate and 24-h ambulatory blood pressure in NIDDM with microalbuminuria: effects of a monounsaturated-enriched diet (1995) (13)
Renal involvement is related to body height in newly diagnosed diabetic women aged 40 years or over. (2001) (12)
Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites. (1995) (12)
Increased QTc Dispersion Is Related to Blunted Circadian Blood Pressure Variation in Normoalbuminuric Type 1 Diabetic Patients (2001) (12)
Danish general practitioners' estimation of urinary albumin concentration in the detection of proteinuria and microalbuminuria. (1995) (12)
Increased myocardial contractility in short-term Type 1 diabetic patients: an echocardiographic study (1985) (11)
Ambulatory pulse pressure and progression of albuminuria in type 2 diabetes: evidence provided, new questions emerge. (2006) (11)
Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design (2003) (11)
Motor pathway function in normoalbuminuric IDDM patients (1995) (11)
Exercise capacity and cardiac function in type 1 diabetic patients treated with continuous subcutaneous insulin infusion. A controlled study. (1986) (11)
Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate. (1995) (11)
New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics (2005) (10)
Early and late changes in the diabetic kidney. (1979) (10)
Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group. (1997) (10)
The management of the type 2 diabetic patient with hypertension – too late and too little: Suggested improvements (2008) (10)
DIABETES AND HYPERTENSION (1979) (10)
Microalbuminuria and short-term prognosis in patients undergoing cardiac surgery. (2009) (10)
Diabetes mellitus and the kidney. (1982) (9)
Insulin Action in Insulin-Dependent Diabetics After Short-Term Thiazide Therapy (1986) (9)
Structural and Functional Alterations in the Diabetic Kidney (1987) (9)
Microalbuminuria, a predictor of proteinuria and early mortality in NIDDM (1990) (9)
Microalbuminuria, renal disease, metabolic syndrome and risks in diabetes (2007) (9)
The diabetic kidney (2006) (9)
Increase in nocturnal blood pressure and progression to microalbuminuria in diabetes. (2003) (9)
Review: Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment (2001) (9)
Diabetic Renal Disease in Patients with Type 2 Diabetes Mellitus (2002) (9)
Microalbuminuria in a population-based cohort: ways of expression of albuminuria (Fredericia Study--second generation). (1994) (9)
[Nephrology and hypertension]. (2003) (9)
Reducing protein in the diabetic diet. (1990) (9)
Micro vascular permeability to albumin and glomerular filtration rate in diabetic and normal children (1979) (9)
Combining antihypertensive agents in early diabetic nephropathy. (1990) (9)
Management of renal disease and hypertension in insulin-dependent diabetes, with an emphasis on early nephropathy. (1992) (9)
Urinary creatinine concentration is inversely related to glycaemic control and the presence of some diabetic complications in patients with newly diagnosed Type 2 diabetes. (2006) (9)
Intravenous insulin decreases urinary albumin excretion in long-term diabetics with nephropathy (1980) (8)
ALBUMIN EXCRETION IN OPERATING SURGEONS AND IN HYPERTENSION (1979) (8)
Long-term antihypertensive treatment (over six years) inhibiting the progression of diabetic nephropathy. (1981) (8)
ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease (2000) (8)
Chromatographic evidence by Sephadex gel filtration of the unrestricted glomerular filtration of inulin. (1968) (8)
Micro-albuminuria and the organ-damage concept in antihypertensive therapy for patients with insulin-dependent diabetes mellitus. (1992) (8)
Low-dose dopamine infusion, renal haemodynamics and urinary albumin excretion rate in insulin-dependent diabetics and in normal man. (1988) (7)
The relationship between microalbuminuria in first generation diabetic and non-diabetic subjects and microalbuminuria and hypertension in the second generation (a population based study). (1997) (7)
Urinary albumin and beta 2-microglobulin excretion rates in patients with systemic lupus erythematosus. (1980) (7)
Clinical features in persons with a family history of diabetes compared to controls (The Second Generation Fredericia Study) (1996) (7)
Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion. (1988) (7)
Endothelial perturbation: a link between non-dipping and retinopathy in type 2 diabetes? (2007) (7)
Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects (2002) (7)
Preventing or postponing renal disease in insulin-dependent diabetes by glycemic and nonglycemic intervention. (1990) (7)
The Abnormal Albuminuria Syndrome in Diabetes (1993) (7)
Practice guidelines for chronic kidney disease. (2004) (6)
Lipoprotein changes during continuous subcutaneous insulin infusion in insulin-dependent diabetic patients. (1986) (6)
Enalapril versus bendroflumethiazide in type 2 diabetes complicated by hypertension. (1994) (6)
Repeated screening for albumin-creatinine ratio in an unselected population. The Ebeltoft Health Promotion Study, a randomized, population-based intervention trial on health test and health conversations with general practitioners. (1994) (6)
Therapeutic interventions in nephropathy of IDDM. (1988) (6)
Microalbuminuria in Perspectives (2002) (6)
Diabetic nephropathy: evidence for renoprotection and practice (2000) (6)
Long-term prognosis for normo- and microalbuminuric type I (insulin-dependent) diabetic patients (1992) (6)
End-Stage Renal Failure in Diabetic Nephropathy: Pathophysiology and Treatment (1985) (6)
The abnormal albuminuria syndrome in diabetes. Microalbuminuria: key to the complications (1993) (6)
Microalbuminuria and diabetic renal disease (1989) (5)
Prorenin and renal function in NIDDM patients with normo‐ and microalbuminuria (1995) (5)
Microalbuminuria and Diabetic Pregnancy (1998) (5)
Renal hypertrophy in experimental diabetes. (1991) (5)
INTERVENTION STRATEGIES FOR MICROALBUMINURIA: THE ROLE OF ANGIOTENSIN II ANTAGONISTS, INCLUDING DUAL BLOCKADE WITH ACE-I AND A RECEPTOR BLOCKER (2000) (5)
The relationship between kidney size and function in short-term diabetic patients (1981) (4)
Albumin excretion during physical exercise in diabetes. Studies on the effect of insulin treatment and of the renal haemodynamic response. (1981) (4)
Peripheral vascular disease is associated with reduced glycosuria in newly diagnosed type 2 diabetic patients. (2004) (4)
Pharmacotherapy of Diabetes (2007) (4)
Renal function and cimetidine. Urinary albumin and beta 2-microglobulin excretion and creatine clearance during cimetidine treatment. (1981) (4)
Pathophysiology of renal changes in diabetes (1985) (4)
Urinary excretion of albumin and beta-2-microglobulin in hypertensive and normotensive renal transplant recipients during urinary diluting and concentrating tests. (1986) (4)
Microalbuminuria: an important warning sign from the laboratory. (1994) (4)
Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes (2009) (4)
Renal protein handling in man, modified by insulin administration, stress situations and hypertension. (1980) (4)
Renal Dysfunction and Hypertension (2016) (3)
Risk Factors and Optimal Blood Pressure Level for Insulin-Dependent Diabetic Patients (1991) (3)
End-state renal failure in diabetic nephropathy: pathophysiology and treatment. (1985) (3)
OR-49: Treatment based on a low dose combination of perindopril and indapamide reduces albuminuria more effectively than enalapril in hypertensive type 2 diabetic patients (2002) (3)
Nephropathy and Hypertension in Diabetic Patients (2000) (3)
Pharmacology of diabetes : present practice and future perspectives (1991) (3)
Progress in diabetes care: introduction. (1998) (3)
Introduction: nature of microalbuminuria, proteinuria, and progressive renal disease. (1995) (2)
[Antihypertensive treatment in diabetic nephropathy]. (1979) (2)
Exercise and the Kidney in Diabetes (1996) (2)
Is renal involvement related to birth weight and adult height? (2001) (2)
Diabetic complications and early treatment using ACE inhibitors: concluding remarks. (1996) (2)
Screening to prevent renal failure in diabetic patients (1996) (2)
OR-82: Microalbuminuria and pulse pressure are powerful predictors of 25-year mortality in type 1 diabetes (2003) (2)
[Evidence-based reduction of complications of type 2 diabetes following intensive antihypertensive treatment]. (1999) (2)
Renal plasma flow in juvenile diabetes. (1981) (2)
The kidney in Type 2 (non-insulin-dependent) diabetes mellitus (1993) (2)
REDUCTION OF BLOOD PRESSURE AND ALBUMINURIA IN HYPERTENSIVE DIABETIC PATIENTS USING CANDESARTAN, LISINOPRIL AND THEIR COMBINATION (DUAL BLOCKADE): 3C.1 (2000) (2)
Reduced glomerular filtration rate and cardiovascular damage in diabetes: a key role for abnormal albuminuria (1992) (2)
United Kingdom Prospective Diabetes Study. (1996) (2)
New England Journal of Medicine, July 12, 1984, pp 89-93 Predicting diabetic nephropathy in insulin-dependent patients (1985) (2)
Clinical and Renal Functional Studies of Diabetic Nephropathy in Humans (1984) (2)
Left ventricular wall mass and wall thickness in insulin dependent diabetic patients without clinical signs of ischaemic heart disease. (1988) (2)
Some aspects of antihypertensive and diuretic treatment in noninsulin-dependent diabetic patients. (1990) (2)
[Vascular impact of anti-hypertensive treatment and renal protection]. (2005) (1)
Faculty Opinions recommendation of Effect of telmisartan on renal outcomes: a randomized trial. (2009) (1)
Notes on the Use of Glucagon in Type 1 Diabetes (2007) (1)
Albuminuria before and during exercise in non insulin-dependent diabetics with and without retinopathy (1986) (1)
Clinical outcome of using insulin at 40 IU/ml and 100 IU/ml in pump treatment. Results of a controlled multi-center trial. (2009) (1)
OVERBEVISENDE EVIDENS FOR REDUKTION AF KOMPLIKATIONER TIL TYPE 2-DIABETES VED INTENSIV ANTIHYPERTENSIV BEHANDLING (1999) (1)
Surrogate end-points in the treatment of hypertension: Renal function with focus on microalbuminuria (1997) (1)
The Heart in Diabetic Nephropathy (1992) (1)
Diabetic Renal and Related Heart Disease (2006) (1)
Association between risk factors and overnight urinary albumin/creatinine ratio--even in its normal range. (1994) (1)
[Insulin pumps and treatment of diabetes]. (2003) (1)
Mistakes, misunderstandings and controversies in diabetes: A review and personal account (2010) (1)
[The natural history of diabetic nephropathy in insulinodependent diabetics and the concept of non-glycemic treatment]. (1989) (1)
Improving prognosis in NIDDM patients (1996) (1)
Optimal management of hypertensive patients with type 2 diabetes and microalbuminuria. (1998) (1)
Ace inhibition in diabetes : challenging renal and vascular disease : proceedings of a symposium, sponsored by Servier International, held on the occasion of the 16th International Diabetes Federation Congress, Helsinki, Finland, July 20-25, 1997 (1998) (1)
[Inhibition of the renin-angiotensin system in type 2 diabetes. New significant results concerning type 2 diabetes and renal disease]. (2001) (1)
Acute renal effects of angiotensin converting enzyme inhibition in microalbuminuric type 1 diabetic patients (2004) (1)
Renal Dysfunction and Hypertension, Focus on Type 2 Diabetes (2005) (1)
The European Association for the Study of Diabetes Annual Meeting, 1998 (1999) (1)
Reduction of blood pressure and albuminuria in hypertensive patients with type 2 diabetes using candesartan, lisinopril and their combination (2000) (1)
Microalbuminuria and long-term survival in non-insulin-dependent diabetes mellitus and the background population (1992) (1)
Pharmacology of the kidney in IDDM patients (1990) (1)
The role of renal biopsy in the clinic Satishkumar A Jayawardene and Neil S. Sheering (2004) (0)
SESSION 2: “Hypertension and Diabetes” (1990) (0)
Glomerular function in man modified by insulin administration stress situation and hypertension (1979) (0)
Myogenic Response in Retinal Arterioles During Acute Hyperglycaemia in vivo (2005) (0)
Benefit of a treatment strategy based on a very low dose combination of perindopril and Indapamide in albuminuric hypertensive type 2 diabetics (2002) (0)
General monitoring of risk factors and late complications (1989) (0)
[Microalbuminuria--a pawn in several games]. (1993) (0)
Routine blood pressure lowering and kidney disease in type 2 diabetes (2009) (0)
Prevention and Treatment of Diabetic Nephropathy: The Role of Blood Pressure Lowering (2010) (0)
Treatment based on a very low dose combination of perindopril and indapamide reduces albuminuria more effectively than enalapril in hypertensive Type 2 diabetic patients: the PREMIER study (2002) (0)
Subject Index, Vol. 29, 1981 (1981) (0)
PS-51-2 Isokinetic muscle strength in long-term IDDM patients in relation to neuropathy (1995) (0)
[Increased working capacity in insulin-dependent diabetics treated with insulin pumps. A controlled study]. (1988) (0)
Hypertension and diabetes: a risky alliance. How can drug therapy improve clinical outcome? Introduction to the symposium. (1997) (0)
[Hypertension and diabetes: mechanisms of elevation of arterial pressure, physiopathologic basis of therapeutic antihypertensives]. (1993) (0)
Response to Masse (1998) (0)
Urinary Albumin Excretion and Dextran Clearance in the Development of Diabetic Glomerulosclerosis (1974) (0)
Ambulatory blood pressure monitoring. Authors' reply (2003) (0)
How Can the Care of Diabetic ESRD Patients Be Improved? (1991) (0)
[Old knowledge about obesity and diabetes]. (2001) (0)
Interview: Diabetes and renal and cardiovascular outcomes (2009) (0)
Early renal involvement and nephropathy. Can treatment modalities be predicted from identification of risk factors in diabetics? (1989) (0)
Oral and Poster Papers Submitted for Presentation at the 5th Congress of the EUGMS “Geriatric Medicine in a Time of Generational Shift September 3–6, 2008 Copenhagen, Denmark (2008) (0)
Scientific Basis for New Guidelines for the Treatment of Hypertension in Type 2 Diabetes (2000) (0)
Blood pressure lowering treatment and the prevention of stroke in the diabetic patient (2004) (0)
Over-mortality in NIDDM (1997) (0)
Contents, Vol. 29, 1981 (1981) (0)
[Diabetes and surgery--an elucidating report?]. (1995) (0)
Subject Index, Vol. 23, 1979 (1979) (0)
Hypertension and diabetes (1985) (0)
Milestones and New Perspectives in Prevention of Type 2 Diabetes and Its Complications (2005) (0)
Renoprotection in diabetes. With special reference to insulin-dependent patients. (1995) (0)
[Coffee and diabetes--something to be really concerned about?]. (2002) (0)
Negative results - Cardiac general Microalbuminuria and short-term prognosis in patients undergoing cardiac surgery (2009) (0)
Risk factors and survival in elderly patients with noninsulin-dependent diabetes. (1990) (0)
Epilogue: summary of several new guidelines on renoprotective treatment strategies to delay progression of renal disease in diabetic patients. (1995) (0)
Introduction, abnormal albuminuria, a key-parameter (1992) (0)
[A trial to prevent development of renal disease]. (1994) (0)
[Diabetic angiopathy]. (2007) (0)
Early Diagnosis of Diabetic Nephropathy (1990) (0)
ADVANCE Master Meeting I of the ADVANCE Glucose-Lowering Arm (2008) (0)
[Is there any documentation for Lyrica in the treatment of painful diabetic neuropathy?]. (2005) (0)
Stages of diabetic nephropathy (1998) (0)
[Diabetic renal disease--is prevention possible? A review based on studies of renal function]. (1984) (0)
[Functional glomerular microangiopathy]. (1979) (0)
Myogenic Response in Retinal Arterioles During Acute Hyperinsulinemia (2010) (0)
Dual blockade with Candesartan Cilexitil and Lisinopril in hypertensive patients with diabetes mellitus (2003) (0)
Microalbuminuria is associated with longer ICU stay and higher mortality in patients undergoing cardiac surgery (2007) (0)
Contents, Vol. 23, 1979 (1979) (0)
Prevention and Early Treatment of Diabetic Renal Disease (1998) (0)
Glomerular Filtration RateandRenalPlasmaFlowinLong- termJuvenile Diabetics without Proteinuria (1975) (0)
Diabetic nephropathy in insulin-dependent diabetes mellitus patients: how to measure progression of disease and effect of treatment. (1991) (0)
Author's response to reviews Title: Predictors of mortality of patients newly diagnosed with clinical type 2 diabetes: a 5-year follow up study Authors: (2010) (0)
Biomarkers of Disease: The early detection of renal impairment in diabetes mellitus. The case for microalbuminuria and other biomarkers (2002) (0)
Hypertension and diabetes mellitus: a risky alliance: how can drug therapy improve clinical outcome? (A panel discussion). (1997) (0)
[HbA1 and type 2 diabetes--what is optimal?]. (2005) (0)
Metoprolol improves heart rate variability in ACE-inhibitor treated type 1 diabetic patients with abnormal albuminuria (2000) (0)
[Focus on intensive therapeutic strategy in type 2-diabetes]. (1998) (0)
[Measurement of postprandial blood glucose level and the necessary difference between the valuable and invaluable]. (2008) (0)
Diabetes, the Kidney, and Hypertension (1992) (0)
Diabetes and renal and cardiovascular outcomes (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Carl Erik Mogensen?

Carl Erik Mogensen is affiliated with the following schools:

Aarhus University